BSE filing, NSE: SHUKRAPHAR. Summary written from the filing by ALFA Finder's alert engine.
Shukra Pharmaceuticals Ltd: key numbers
- Share price
- ₹78.14
- Market cap
- ₹3,458 Cr
- Revenue (annual)
- ₹56.73 Cr
- Net profit (annual)
- ₹22.06 Cr
- P/E (TTM)
- 101.8×Sector 46.1×
- Promoter holding
- 51.15%+0.19% QoQ
- FII holding
- 0.43%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shukra Pharmaceuticals Ltd
All →Shukra Pharmaceuticals Board Meeting Date
Shukra Medtech Limited has scheduled a board meeting on November 3, 2026, to consider and approve its unaudited financial results for the quarter ended September 2026.
Shukra Pharmaceuticals Other Announcement
Shukra Medtech submitted a revised CA certificate to NSE for its name and symbol change application. The filing requests final exchange approval for the corporate rename.
Shukra Pharmaceuticals Other Announcement
Shukra Pharmaceuticals Limited has submitted the certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Shukra Pharmaceuticals Capital Structure Change
Shukra Pharmaceuticals allotted 17.35 lakh equity shares upon warrant conversion to promoters. The exercise raised Rs. 4.63 Crore, increasing the paid-up capital.
- Value
- ₹4.63 Cr
Shukra Pharmaceuticals Price Movement Clarification
Shukra Pharmaceuticals clarified that the recent share price movement is market-driven. The company confirmed no undisclosed, price-sensitive information exists.
Shukra Pharmaceuticals Annual General Meeting
Shukra Pharmaceuticals Ltd issued a corrigendum to its Postal Ballot notice regarding the proposed alteration of its Main Object Clause and name change.
Other management change announcements
All →Integrated Proteins Management Change
Integrated Proteins appointed Ms. Arushi Aggarwal as Company Secretary and Compliance Officer, effective 29 October 2026. The appointment was approved at a board meeting as a Key Managerial Personnel change.
Suraj Management Change
Suraj Limited appointed Mr. Mayank Balvantbhai Rami as Company Secretary and Compliance Officer effective November 1, 2026. The board approved this KMP appointment on October 29, 2026.
Superior Finlease Management Change
Superior Finlease disclosed that Mr. Krishan Gopal Sharma resigned as CFO and KMP effective 28 Oct 2026 due to personal commitments. No successor is named yet.
Vertex Securities Management Change
Vertex Securities appointed Ms. Unni as Independent Director and Mr. Iyer as CFO, effective October 2026. Both roles were approved at the 28 October board meeting.
Kirloskar Brothers Management Change
Kirloskar Brothers' Independent Directors Vivek Pendharkar and Rekha Sethi completed their 5-year terms on 28 Oct 2026. They ceased from the Board and all committees.
iStreet Network Management Change
iStreet Network Ltd announced the resignation of Non-Executive Non-Independent Director Mr. Yash Maheshwari effective 13 October 2026. No financial impact is indicated.